CRVS — Corvus Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(CRVS)

Corvus Pharmaceuticals, Inc.

Live chart and latest CRVS stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

CRVS News

Is Corvus Pharmaceuticals (CRVS) Still Attractive After Its Recent Share Price Surge

Feb 16, 2026 Seeking Alpha

Corvus Pharmaceuticals: Strong Clinical Narrative, Already Priced For Success

Apr 8, 2026 Investing.com

Corvus Pharma stock falls after announcing $150 million offering

Jan 20, 2026 Stock Titan

Corvus Pharmaceuticals (NASDAQ: CRVS) launches $200M at-the-market stock program

Mar 13, 2026 simplywall.st

A Look At Corvus Pharmaceuticals (CRVS) Valuation After Recent Share Price Swings

Mar 15, 2026 Investor's Business Daily

Why Small Biotech Stock Corvus Pharma Just Launched To A Nine-Year High

Jan 20, 2026 TradingView — Track All Markets

What made Corvus stock double on Tuesday and is it sustainable?

Jan 20, 2026 Yahoo Finance

Corvus Pharmaceuticals Stock Rallies 209% in a Month: Here's Why

Jan 27, 2026 Seeking Alpha

Soquelitinib Data Push Corvus Pharmaceuticals Stock Higher: What You Should Know (CRVS)

Jan 21, 2026 Investing.com

Mizuho raises Corvus Pharmaceuticals stock price target to $20 on strong trial data

Jan 20, 2026 Stock Titan

Corvus Pharma raises $175M to advance lymphoma and atopic dermatitis trials

Jan 21, 2026 simplywall.st

Is Corvus Pharmaceuticals (CRVS) Now Attractive After Recent Share Price Volatility?

Mar 9, 2026 Yahoo Finance

Corvus Pharmaceuticals (CRVS) Is Up 211.80% in One Week: What You Should Know

Jan 27, 2026 Stock Titan

Corvus eczema drug improves key symptoms for 75% in early trial

Jan 20, 2026 Investing.com

Corvus Pharmaceuticals stock price target raised to $27 from $11 at H.C. Wainwright